CAS 152317-89-0

Alniditan

Description:

Alniditan is a chemical compound primarily recognized for its use as a medication in the treatment of migraine headaches. It belongs to the class of drugs known as triptans, which are specifically designed to alleviate migraine symptoms by acting as agonists at serotonin receptors, particularly the 5-HT_1B and 5-HT_1D subtypes. This action leads to vasoconstriction of cranial blood vessels and inhibition of pro-inflammatory neuropeptide release, effectively reducing headache intensity. Alniditan is characterized by its relatively rapid onset of action and a favorable pharmacokinetic profile, which includes good oral bioavailability. Its chemical structure features a unique arrangement of functional groups that contribute to its biological activity. While it is effective for migraine relief, potential side effects may include dizziness, fatigue, and sensations of heaviness or tightness. As with any medication, it is essential for users to consult healthcare professionals for appropriate usage and to discuss any contraindications or interactions with other medications.

Formula: C₁₇H₂₆N₄O

InChI: InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1

InChI key: InChIKey=QVSXOXCYXPQXMF-OAHLLOKOSA-N

SMILES: C(NCCCNC=1NCCCN1)[C@@H]2OC=3C(CC2)=CC=CC3

Synonyms:

• (-)-2-((3-(((R)-2-Chromanylmethyl)amino)propyl)amino)-1,4,5,6-tetrahydropyrimidine dihydrochloride
• (R)-N-((3,4-Dihydro-2H-1-benzopyran-2-yl)methyl)-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine dihydrochloride
• 1,3-Propanediamine, N-((3,4-dihydro-2H-1-benzopyran-2-yl)methyl)-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-,dihydrochloride, (R)-
• 1,3-Propanediamine, N-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-N′-(1,4,5,6-tetrahydro-2-pyrimidinyl)-, (R)-
• 1,3-Propanediamine, N-[[(2R)-3,4-dihydro-2H-1-benzopyran-2-yl]methyl]-N′-(1,4,5,6-tetrahydro-2-pyrimidinyl)-
• 1,3-Propanediamine, N¹-[[(2R)-3,4-dihydro-2H-1-benzopyran-2-yl]methyl]-N³-(1,4,5,6-tetrahydro-2-pyrimidinyl)-
• 2-[[3-[[(R)-2-Chromanylmethyl]amino]propyl]amino]-1,4,5,6-tetrahydropyrimidine
• Alniditan HCl
• Alniditan dihydrochloride
• Alniditan dihydrochloride [USAN]
• Alnitidan
• N-(3,4-Dihydro-2H-1-benzopyran-2-yl methyl)-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine dihydrochloride
• N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
• N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine dihydrochloride
• N¹-[[(2R)-3,4-Dihydro-2H-1-benzopyran-2-yl]methyl]-N³-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine
• 1,3-Propanediamine, N1-[[(2R)-3,4-dihydro-2H-1-benzopyran-2-yl]methyl]-N3-(1,4,5,6-tetrahydro-2-pyrimidinyl)-

Alniditan

CAS: 152317-89-0

Alniditan is a diagnostic agent that is used for the detection of 5-HT1A receptors in vivo. It has been shown to be an absorption enhancer and is able to cross the blood-brain barrier. Alniditan binds to the 5-HT1A receptor, which is a neurotransmitter receptor that regulates mood, appetite, and sleep. Alniditan has been shown to inhibit the production of messenger RNA (mRNA) in rat hippocampal formation cells, as well as its binding with human serum proteins. This drug also has a high affinity for fatty acid receptors and exhibits agonist activity at these sites.

Formula: C₁₇H₂₆N₄O

Purity: Min. 95%

Molecular weight: 302.4 g/mol

Ref: 3D-CGA31789

Alniditan

CAS: 152317-89-0

Alniditan is a receptors agonist of 5-HT1B/1D in HEK 293 cells (IC50: 1.7 and 1.3 nM). For 5-HT1B/1D receptors, the pKi values are 8.96 and 9.40, respectively.

Formula: C₁₇H₂₆N₄O

Purity: 98%

Color and Shape: Solid

Molecular weight: 302.41

Ref: TM-T14190